Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands; Department of Medical Genetics, Biomedical Genetics, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.
William Harvey Research Institute National Institute for Health Biomedical Research Unit, Barts and the London School of Medicine, Queen Mary University of London, London EC1M 6BQ, UK.
Am J Hum Genet. 2014 Mar 6;94(3):349-60. doi: 10.1016/j.ajhg.2013.12.016. Epub 2014 Feb 20.
Blood pressure (BP) is a heritable risk factor for cardiovascular disease. To investigate genetic associations with systolic BP (SBP), diastolic BP (DBP), mean arterial pressure (MAP), and pulse pressure (PP), we genotyped ~50,000 SNPs in up to 87,736 individuals of European ancestry and combined these in a meta-analysis. We replicated findings in an independent set of 68,368 individuals of European ancestry. Our analyses identified 11 previously undescribed associations in independent loci containing 31 genes including PDE1A, HLA-DQB1, CDK6, PRKAG2, VCL, H19, NUCB2, RELA, HOXC@ complex, FBN1, and NFAT5 at the Bonferroni-corrected array-wide significance threshold (p < 6 × 10(-7)) and confirmed 27 previously reported associations. Bioinformatic analysis of the 11 loci provided support for a putative role in hypertension of several genes, such as CDK6 and NUCB2. Analysis of potential pharmacological targets in databases of small molecules showed that ten of the genes are predicted to be a target for small molecules. In summary, we identified previously unknown loci associated with BP. Our findings extend our understanding of genes involved in BP regulation, which may provide new targets for therapeutic intervention or drug response stratification.
血压(BP)是心血管疾病的遗传风险因素。为了研究与收缩压(SBP)、舒张压(DBP)、平均动脉压(MAP)和脉压(PP)相关的遗传关联,我们对多达 87736 名欧洲血统个体中的约 50000 个 SNP 进行了基因分型,并在meta 分析中进行了合并。我们在一个独立的包含 68368 名欧洲血统个体的独立样本中复制了发现结果。我们的分析在独立的含 31 个基因的位点中鉴定了 11 个以前未描述的关联,这些基因包括 PDE1A、HLA-DQB1、CDK6、PRKAG2、VCL、H19、NUCB2、RELA、HOXC@ 复合物、FBN1 和 NFAT5,在 Bonferroni 校正的全阵列显着性阈值(p < 6×10(-7)) 下发现了 11 个以前未描述的关联,并证实了 27 个先前报道的关联。对 11 个位点的生物信息学分析为几个基因(如 CDK6 和 NUCB2)在高血压中的潜在作用提供了支持。对小分子数据库中潜在药理靶点的分析表明,这 10 个基因可能是小分子的靶点。总之,我们确定了与 BP 相关的以前未知的位点。我们的研究结果扩展了我们对参与 BP 调节的基因的理解,这可能为治疗干预或药物反应分层提供新的靶点。